Trials / Completed
CompletedNCT02442219
A Blood Based Diagnostic Test for Coeliac Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 144 (estimated)
- Sponsor
- Oslo University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Persons with coeliac disease treated with a gluten free diet will be asked to give blood for a new diagnostic blood test. In this test investigators will use multimerized HLA bound to different gliadin-peptides (tetramer) and with the help of a flow-cytometer identify (along with other relevant T-cell-markers) gluten specific T-cells. Investigators believe that these cells will be present in persons with coeliac disease regardless of gluten-intake. Investigators will compare their findings with two control groups; Persons on a gluten free diet where celiac disease is excluded (gluten sensitive group) and persons on a gluten containing diet (healthy control group). In the initial and main study investigators will look at HLA DQ2.5 individuals, which comprise \>90% of all persons with coeliac disease.
Conditions
Timeline
- Start date
- 2015-02-01
- Primary completion
- 2025-07-28
- Completion
- 2025-07-28
- First posted
- 2015-05-13
- Last updated
- 2025-07-30
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT02442219. Inclusion in this directory is not an endorsement.